These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15269303)

  • 21. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
    Carrillo E; Marchal JA; Prados J; Melguizo C; Vélez C; Arena N; Alvarez L; Serrano S; Aránega A
    Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1247-52. PubMed ID: 9874512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of tyrosinase reverse transcriptase PCR analysis in melanoma sentinel lymph nodes: long-term follow-up analysis.
    González Cao M; Badenas C; Malvehy J; Martí R; Puig-Butille JA; Castel T; Rull R; Vilalta A; Vidal-Sicart S; Palou J; Vilella R; Conill C; Sánchez M; Walker G; Pons F; Puig S
    Clin Exp Dermatol; 2009 Dec; 34(8):863-9. PubMed ID: 19438551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The detection of melanoma metastases in sentinel nodes by polymerase chain reaction].
    Poelman M; van der Velde-Zimmermann D; van Doorn LJ; Quint WG; van Krimpen C; de Graaf PW
    Ned Tijdschr Geneeskd; 1998 Apr; 142(16):905-8. PubMed ID: 9623187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction.
    Lukowsky A; Bellmann B; Ringk A; Winter H; Audring H; Fenske S; Sterry W
    J Invest Dermatol; 1999 Oct; 113(4):554-9. PubMed ID: 10504440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome.
    Romanini A; Manca G; Pellegrino D; Murr R; Sarti S; Bianchi F; Alsharif A; Orlandini C; Zucchi V; Castagna M; Gandini D; Salimbeni G; Ghiara F; Barachini P; Mariani G
    Ann Oncol; 2005 Nov; 16(11):1832-40. PubMed ID: 16107497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.
    de Vries TJ; Fourkour A; Punt CJ; Ruiter DJ; van Muijen GN
    Melanoma Res; 2000 Apr; 10(2):119-26. PubMed ID: 10803712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies.
    Gutzmer R; Kaspari M; Brodersen JP; Mommert S; Völker B; Kapp A; Werfel T; Kiehl P
    Histopathology; 2002 Dec; 41(6):510-8. PubMed ID: 12460203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases].
    Riccioni L; Farabegoli P; Nanni O; Morigi F; Polverelli M; Landi G; Giangaspero F
    Pathologica; 2002 Aug; 94(4):190-5. PubMed ID: 12325417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
    Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
    Ringhoffer M; Schmitt M; Karbach J; Jäger E; Oesch F; Arand M
    Int J Oncol; 2001 Nov; 19(5):983-9. PubMed ID: 11604998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan.
    Ito T; Moroi Y; Oba J; Nakahara T; Takeuchi S; Uchi H; Takahara M; Masuda T; Furue M
    Melanoma Res; 2012 Feb; 22(1):38-44. PubMed ID: 22108607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes.
    Calogero A; Timmer-Bosscha H; Schraffordt Koops H; Tiebosch AT; Mulder NH; Hospers GA
    Br J Cancer; 2000 Jul; 83(2):184-7. PubMed ID: 10901368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
    Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
    Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic search for the best gene expression markers for melanoma micrometastasis detection.
    Soikkeli J; Lukk M; Nummela P; Virolainen S; Jahkola T; Katainen R; Harju L; Ukkonen E; Saksela O; Hölttä E
    J Pathol; 2007 Oct; 213(2):180-9. PubMed ID: 17891747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate.
    Davids V; Kidson SH; Hanekom GS
    Mol Pathol; 2003 Feb; 56(1):43-51. PubMed ID: 12560463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
    Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
    Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between three molecular methods for detection of blood melanoma tyrosinase mRNA. Correlation with melanoma stages and S100B, LDH, NSE biochemical markers.
    Santonocito C; Concolino P; Lavieri MM; Ameglio F; Gentileschi S; Capizzi R; Rocchetti S; Amerio P; Castagnola M; Zuppi C; Capoluongo E
    Clin Chim Acta; 2005 Dec; 362(1-2):85-93. PubMed ID: 16054123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin.
    Blaheta HJ; Schittek B; Breuninger H; Sotlar K; Ellwanger U; Thelen MH; Maczey E; Rassner G; Bueltmann B; Garbe C
    Am J Surg Pathol; 1999 Jul; 23(7):822-8. PubMed ID: 10403306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients.
    Xu Y; Theobald V; Sung C; DePalma K; Atwater L; Seiger K; Perricone MA; Richards SM
    J Transl Med; 2008 Oct; 6():61. PubMed ID: 18945350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.